Ribomic Inc. (TYO:4591)
Japan · Delayed Price · Currency is JPY 75.00
-1.00 (-1.32%)
Oct 6, 2026, 3:30 PM JST
Ribomic Market Cap
Ribomic has a market cap or net worth of 4.24 billion as of October 6, 2026. Its market cap has decreased by -0.92% in one year.
Market Cap
4.24B
Enterprise Value
1.46B
Revenue
7.50M
Ranking
n/a
PE Ratio
n/a
Stock Price
75.00
ChartMarket Cap Chart
Since September 25, 2014, Ribomic's market cap has decreased from 22.97B to 4.24B, a decrease of -81.54%. That is a compound annual growth rate of -13.09%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 6, 2026 | 4.24B | 2.96% |
| Dec 30, 2025 | 4.12B | 20.26% |
| Dec 30, 2024 | 3.43B | -11.13% |
| Dec 29, 2023 | 3.85B | -41.00% |
| Dec 30, 2022 | 6.53B | -43.16% |
| Dec 30, 2021 | 11.49B | 13.74% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| TMS Co., Ltd. | 5.75B |
| Soiken Holdings | 5.62B |
| PRISM BioLab Co.,LTD | 5.40B |
| Noile-Immune Biotech | 5.08B |
| Chordia Therapeutics | 4.79B |
| D. Western Therapeutics Institute | 4.26B |
| Kohjin Bio | 4.21B |
| Kringle Pharma | 4.06B |